- Lipocine Announces Financial Results For The Year Ended December 31, 2020
- Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners Conference
- Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis
- Lipocine Announces Presentations on TLANDO™ at ENDO 2021 Conference
- Lipocine to Present at Two Upcoming Investor Conferences
- Lipocine Closes Underwritten Public Offering Of Common Stock
- Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock
- Lipocine Announces Launch Of Public Offering Of Common Stock
As of last trade
Lipocine Inc (2VT:FRA) traded at 1.20, -39.44% below its 52-week high of 1.98, set on Jan 21, 2021.
0.41Apr 20 20201.98Jan 21 2021
Markit short selling activity
|Market cap||128.90m USD|
|EPS (TTM)||-0.4017 |
Data delayed at least 15 minutes, as of Apr 19 2021 07:00 BST.